-
1
-
-
0036379686
-
Patient survival after renal transplantation: IV. Impact of post-transplant diabetes
-
Cosio FG, Pesavento TE, Kim S, et al. Patient survival after renal transplantation: IV. Impact of post-transplant diabetes. Kidney Int 2002; 62: 1440-6
-
(2002)
Kidney Int
, vol.62
, pp. 1440-1446
-
-
Cosio, F.G.1
Pesavento, T.E.2
Kim, S.3
-
2
-
-
0035095701
-
Influence of diabetes mellitus on patient and graft survival in recipients of kidney transplantation
-
Revanur VK, Jardine AG, Kingsmore DB, et al. Influence of diabetes mellitus on patient and graft survival in recipients of kidney transplantation. Clin Transplant 2001; 15: 89-94
-
(2001)
Clin Transplant
, vol.15
, pp. 89-94
-
-
Revanur, V.K.1
Jardine, A.G.2
Kingsmore, D.B.3
-
3
-
-
0345870154
-
Development of diabetes mellitus post-renal transplantation is associated with poor short-term clinical outcomes
-
Saleem TF, Cunningham KE, Hollenbeak CS, et al. Development of diabetes mellitus post-renal transplantation is associated with poor short-term clinical outcomes. Transplant Proc 2003; 35: 2916-8
-
(2003)
Transplant Proc
, vol.35
, pp. 2916-2918
-
-
Saleem, T.F.1
Cunningham, K.E.2
Hollenbeak, C.S.3
-
4
-
-
21244451586
-
Random blood glucose measurements and survival in nondiabetic renal transplant recipients
-
Tutone VK, Mark PB, Revanur V, et al. Random blood glucose measurements and survival in nondiabetic renal transplant recipients. Transplant Proc 2004; 36: 3006-11
-
(2004)
Transplant Proc
, vol.36
, pp. 3006-3011
-
-
Tutone, V.K.1
Mark, P.B.2
Revanur, V.3
-
5
-
-
0035722250
-
Risk factors for post-transplant tuberculosis
-
John GT, Shankar V, Abraham AM, et al. Risk factors for post-transplant tuberculosis. Kidney Int 2001; 60: 1148-53
-
(2001)
Kidney Int
, vol.60
, pp. 1148-1153
-
-
John, G.T.1
Shankar, V.2
Abraham, A.M.3
-
6
-
-
0037910288
-
Epidemiology of systemic mycoses among renal-transplant recipients in India
-
Tharayil JG, Shankar V, Talaulikar G, et al. Epidemiology of systemic mycoses among renal-transplant recipients in India. Transplantation 2003; 75: 1544-51
-
(2003)
Transplantation
, vol.75
, pp. 1544-1551
-
-
Tharayil, J.G.1
Shankar, V.2
Talaulikar, G.3
-
7
-
-
29544441578
-
Cardiovascular risk factors in diabetic patients with renal transplants
-
Diaz JM, Sainz Z, Gich I, et al. Cardiovascular risk factors in diabetic patients with renal transplants. Transplant Proc 2005; 37: 3802-4
-
(2005)
Transplant Proc
, vol.37
, pp. 3802-3804
-
-
Diaz, J.M.1
Sainz, Z.2
Gich, I.3
-
8
-
-
23044499556
-
New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation
-
Cosio FG, Kudva Y, van der Velde M, et al. New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation. Kidney Int 2005; 67: 2415-21
-
(2005)
Kidney Int
, vol.67
, pp. 2415-2421
-
-
Cosio, F.G.1
Kudva, Y.2
Van Der Velde, M.3
-
9
-
-
14044273016
-
Posttransplant diabetes mellitus and atherosclerotic events in renal transplant recipients: A prospective study
-
Ducloux D, Kazory A, Chalopin JM. Posttransplant diabetes mellitus and atherosclerotic events in renal transplant recipients: a prospective study. Transplantation 2005; 79: 438-43
-
(2005)
Transplantation
, vol.79
, pp. 438-443
-
-
Ducloux, D.1
Kazory, A.2
Chalopin, J.M.3
-
10
-
-
33750518900
-
-
[online]. Available from URL: [Accessed 2006 Jun]
-
The Organ Procurement and Transplantation Network [online]. Available from URL: http://www.optn.org/Data/rptData.asp [Accessed 2006 Jun]
-
-
-
-
11
-
-
33846853461
-
Clinical practice recommendations
-
American Diabetes Association
-
American Diabetes Association. Clinical practice recommendations. Diabetes Care 2006; 29 Suppl.: S43-8
-
(2006)
Diabetes Care
, vol.29
, Issue.SUPPL.
-
-
-
12
-
-
26644438094
-
Home glucometer monitoring markedly improves diagnosis of post renal transplant diabetes mellitus in renal transplant recipients
-
Shah A, Kendall G, Demme RA, et al. Home glucometer monitoring markedly improves diagnosis of post renal transplant diabetes mellitus in renal transplant recipients. Transplantation 2005; 80: 775-81
-
(2005)
Transplantation
, vol.80
, pp. 775-781
-
-
Shah, A.1
Kendall, G.2
Demme, R.A.3
-
13
-
-
0031752685
-
Global burden of diabetes, 1995-2025: Prevalence, numerical estimates, and projections
-
King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998; 21: 1414-31
-
(1998)
Diabetes Care
, vol.21
, pp. 1414-1431
-
-
King, H.1
Aubert, R.E.2
Herman, W.H.3
-
14
-
-
2342466734
-
Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030
-
Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-53
-
(2004)
Diabetes Care
, vol.27
, pp. 1047-1053
-
-
Wild, S.1
Roglic, G.2
Green, A.3
-
15
-
-
0035850402
-
The continuing epidemics of obesity and diabetes in the United States
-
Mokdad AH, Bowman BA, Ford ES, et al. The continuing epidemics of obesity and diabetes in the United States. JAMA 2001; 286: 1195-200
-
(2001)
JAMA
, vol.286
, pp. 1195-1200
-
-
Mokdad, A.H.1
Bowman, B.A.2
Ford, E.S.3
-
16
-
-
0035126824
-
Influence of tacrolimus on glucose metabolism before and after renal transplantation: A prospective study
-
Duijnhoven EM, Boots JM, Christiaans MH, et al. Influence of tacrolimus on glucose metabolism before and after renal transplantation: a prospective study. J Am Soc Nephrol 2001; 12: 583-8
-
(2001)
J Am Soc Nephrol
, vol.12
, pp. 583-588
-
-
Duijnhoven, E.M.1
Boots, J.M.2
Christiaans, M.H.3
-
17
-
-
0035958103
-
Beta-cell dysfunction rather than insulin resistance is the main contributing factor for the development of postrenal transplantation diabetes mellitus
-
Nam JH, Mun JI, Kim SI, et al. Beta-cell dysfunction rather than insulin resistance is the main contributing factor for the development of postrenal transplantation diabetes mellitus. Transplantation 2001; 71: 1417-23
-
(2001)
Transplantation
, vol.71
, pp. 1417-1423
-
-
Nam, J.H.1
Mun, J.I.2
Kim, S.I.3
-
18
-
-
10744233539
-
Diabetes mellitus after transplant: Relationship to pretransplant glucose metabolism and tacrolimus or cyclosporine A-based therapy
-
Sato T, Inagaki A, Uchida K, et al. Diabetes mellitus after transplant: relationship to pretransplant glucose metabolism and tacrolimus or cyclosporine A-based therapy. Transplantation 2003; 76: 1320-6
-
(2003)
Transplantation
, vol.76
, pp. 1320-1326
-
-
Sato, T.1
Inagaki, A.2
Uchida, K.3
-
19
-
-
0018420446
-
Diabetes mellitus: A more-common-than-believed complication of renal transplantation
-
Gunnarsson R, Arner P, Lundgren G, et al. Diabetes mellitus: a more-common-than-believed complication of renal transplantation. Transplant Proc 1979; 11: 1280-1
-
(1979)
Transplant Proc
, vol.11
, pp. 1280-1281
-
-
Gunnarsson, R.1
Arner, P.2
Lundgren, G.3
-
20
-
-
0026092365
-
Diabetes mellitus after renal transplantation in the cyclosporine era: An analysis of risk factors
-
Sumrani NB, Delaney V, Ding ZK, et al. Diabetes mellitus after renal transplantation in the cyclosporine era: an analysis of risk factors. Transplantation 1991; 51: 343-7
-
(1991)
Transplantation
, vol.51
, pp. 343-347
-
-
Sumrani, N.B.1
Delaney, V.2
Ding, Z.K.3
-
21
-
-
0035132552
-
Post-transplant diabetes mellitus: Increasing incidence in renal allograft recipients transplanted in recent years
-
Cosio FG, Pesavento TE, Osei K, et al. Post-transplant diabetes mellitus: increasing incidence in renal allograft recipients transplanted in recent years. Kidney Int 2001; 59: 732-7
-
(2001)
Kidney Int
, vol.59
, pp. 732-737
-
-
Cosio, F.G.1
Pesavento, T.E.2
Osei, K.3
-
22
-
-
0037297155
-
Diabetes mellitus after kidney transplantation in the United States
-
Kasiske BL, Snyder JJ, Gilbertson D, et al. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003; 3: 178-85
-
(2003)
Am J Transplant
, vol.3
, pp. 178-185
-
-
Kasiske, B.L.1
Snyder, J.J.2
Gilbertson, D.3
-
23
-
-
0016756788
-
Hyperosmolar nonketotic syndrome and steroid diabetes: Occurrence after renal transplantation
-
Woods JE, Zincke H, Palumbo PJ, et al. Hyperosmolar nonketotic syndrome and steroid diabetes: occurrence after renal transplantation. JAMA 1975; 231: 1261-3
-
(1975)
JAMA
, vol.231
, pp. 1261-1263
-
-
Woods, J.E.1
Zincke, H.2
Palumbo, P.J.3
-
24
-
-
84943430958
-
HLA-A28 and steroid-induced diabetes in renal transplant patients
-
David DS, Cheigh JS, Braun Jr DW, et al. HLA-A28 and steroid-induced diabetes in renal transplant patients. JAMA 1980; 243: 532-3
-
(1980)
JAMA
, vol.243
, pp. 532-533
-
-
David, D.S.1
Cheigh, J.S.2
Braun Jr., D.W.3
-
25
-
-
32844474104
-
Posttransplant diabetes mellitus in kidney transplant recipients receiving calcineurin or mTOR inhibitor drugs
-
Araki M, Flechner SM, Ismail HR, et al. Posttransplant diabetes mellitus in kidney transplant recipients receiving calcineurin or mTOR inhibitor drugs. Transplantation 2006; 81: 335-41
-
(2006)
Transplantation
, vol.81
, pp. 335-341
-
-
Araki, M.1
Flechner, S.M.2
Ismail, H.R.3
-
26
-
-
0023230559
-
The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients
-
Boudreaux JP, McHugh L, Canafax DM, et al. The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients. Transplantation 1987; 44: 376-81
-
(1987)
Transplantation
, vol.44
, pp. 376-381
-
-
Boudreaux, J.P.1
McHugh, L.2
Canafax, D.M.3
-
27
-
-
0033610677
-
The effects of maintenance doses of FK506 versus cyclosporin A on glucose and lipid metabolism after orthotopic liver transplantation
-
Fernandez LA, Lehmann R, Luzi L, et al. The effects of maintenance doses of FK506 versus cyclosporin A on glucose and lipid metabolism after orthotopic liver transplantation. Transplantation 1999; 68: 1532-41
-
(1999)
Transplantation
, vol.68
, pp. 1532-1541
-
-
Fernandez, L.A.1
Lehmann, R.2
Luzi, L.3
-
28
-
-
0036310155
-
NFAT regulates insulin gene promoter activity in response to synergistic pathways induced by glucose and glucagon-like peptide-1
-
Lawrence MC, Bhatt HS, Easom RA. NFAT regulates insulin gene promoter activity in response to synergistic pathways induced by glucose and glucagon-like peptide-1. Diabetes 2002; 51: 691-8
-
(2002)
Diabetes
, vol.51
, pp. 691-698
-
-
Lawrence, M.C.1
Bhatt, H.S.2
Easom, R.A.3
-
29
-
-
0034796114
-
Regulation of insulin gene transcription by a Ca(2+)-responsive pathway involving calcineurin and nuclear factor of activated T cells
-
Lawrence MC, Bhatt HS, Watterson JM, et al. Regulation of insulin gene transcription by a Ca(2+)-responsive pathway involving calcineurin and nuclear factor of activated T cells. Mol Endocrinol 2001; 15: 1758-67
-
(2001)
Mol Endocrinol
, vol.15
, pp. 1758-1767
-
-
Lawrence, M.C.1
Bhatt, H.S.2
Watterson, J.M.3
-
30
-
-
0028168125
-
Interaction of tacrolimus (FK506) and its metabolites with FKBP and calcineurin
-
Tamura K, Fujimura T, Iwasaki K, et al. Interaction of tacrolimus (FK506) and its metabolites with FKBP and calcineurin. Biochem Biophys Res Commun 1994; 202: 437-43
-
(1994)
Biochem Biophys Res Commun
, vol.202
, pp. 437-443
-
-
Tamura, K.1
Fujimura, T.2
Iwasaki, K.3
-
31
-
-
0029056853
-
Transcriptional inhibition of insulin by FK506 and possible involvement of FK506 binding protein-12 in pancreatic beta-cell
-
Tamura K, Fujimura T, Tsutsumi T, et al. Transcriptional inhibition of insulin by FK506 and possible involvement of FK506 binding protein-12 in pancreatic beta-cell. Transplantation 1995; 59: 1606-13
-
(1995)
Transplantation
, vol.59
, pp. 1606-1613
-
-
Tamura, K.1
Fujimura, T.2
Tsutsumi, T.3
-
32
-
-
0030474003
-
Mechanisms of inhibition of insulin release
-
Sharp GW. Mechanisms of inhibition of insulin release. Am J Physiol 1996; 271 (Pt 1): C1781-99
-
(1996)
Am J Physiol
, vol.271
, Issue.PART 1
-
-
Sharp, G.W.1
-
33
-
-
0032541081
-
Gene-specific transcriptional activity of the insulin cAMP-responsive element is conferred by NF-Y in combination with cAMP response element-binding protein
-
Eggers A, Siemann G, Blume R, et al. Gene-specific transcriptional activity of the insulin cAMP-responsive element is conferred by NF-Y in combination with cAMP response element-binding protein. J Biol Chem 1998; 273: 18499-508
-
(1998)
J Biol Chem
, vol.273
, pp. 18499-18508
-
-
Eggers, A.1
Siemann, G.2
Blume, R.3
-
34
-
-
0032976902
-
Inhibition of cyclic AMP response element-binding protein/cyclic AMP response element-mediated transcription by the immunosuppressive drugs cyclosporin A and FK506 depends on the promoter context
-
Siemann G, Blume R, Grapentin D, et al. Inhibition of cyclic AMP response element-binding protein/cyclic AMP response element-mediated transcription by the immunosuppressive drugs cyclosporin A and FK506 depends on the promoter context. Mol Pharmacol 1999; 55: 1094-100
-
(1999)
Mol Pharmacol
, vol.55
, pp. 1094-1100
-
-
Siemann, G.1
Blume, R.2
Grapentin, D.3
-
35
-
-
0038339191
-
cAMP promotes pancreatic beta-cell survival via CREB-mediated induction of IRS2
-
Jhala US, Canettieri G, Screaton RA, et al. cAMP promotes pancreatic beta-cell survival via CREB-mediated induction of IRS2. Genes Dev 2003; 17: 1575-80
-
(2003)
Genes Dev
, vol.17
, pp. 1575-1580
-
-
Jhala, U.S.1
Canettieri, G.2
Screaton, R.A.3
-
36
-
-
0029774262
-
Impaired cAMP-mediated gene expression and decreased cAMP response element binding protein in senescent cells
-
Chin JH, Okazaki N, Frazier JS, et al. Impaired cAMP-mediated gene expression and decreased cAMP response element binding protein in senescent cells. Am J Physiol 1996; 27: C362-71
-
(1996)
Am J Physiol
, vol.27
-
-
Chin, J.H.1
Okazaki, N.2
Frazier, J.S.3
-
37
-
-
33646873040
-
Downstream molecular events in the altered profiles of lysophosphatidic acid-induced cAMP in senescent human diploid fibroblasts
-
Jang IS, Rhim JH, Park S, et al. Downstream molecular events in the altered profiles of lysophosphatidic acid-induced cAMP in senescent human diploid fibroblasts. Exp Mol Med 2006; 38: 134-43
-
(2006)
Exp Mol Med
, vol.38
, pp. 134-143
-
-
Jang, I.S.1
Rhim, J.H.2
Park, S.3
-
38
-
-
0025946452
-
Mechanisms of action of cyclosporin A on islet alpha- and beta-cells: Effects on cAMP- and calcium-dependent pathways
-
Martin F, Bedoya FJ. Mechanisms of action of cyclosporin A on islet alpha- and beta-cells: effects on cAMP- and calcium-dependent pathways. Life Sci 1991; 49: 1915-21
-
(1991)
Life Sci
, vol.49
, pp. 1915-1921
-
-
Martin, F.1
Bedoya, F.J.2
-
39
-
-
1942502245
-
New onset diabetes mellitus in patients receiving calcineurin inhibitors: A systematic review and metaanalysis
-
Heisel O, Heisel R, Balshaw R, et al. New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and metaanalysis. Am J Transplant 2004; 4: 583-95
-
(2004)
Am J Transplant
, vol.4
, pp. 583-595
-
-
Heisel, O.1
Heisel, R.2
Balshaw, R.3
-
40
-
-
0037006627
-
Efficacy and safety of tacrolimus compared with cyclosporine microemulsion in renal transplantation: A randomized multicenter study
-
Margreiter R. Efficacy and safety of tacrolimus compared with cyclosporine microemulsion in renal transplantation: a randomized multicenter study. Lancet 2002; 359: 741-6
-
(2002)
Lancet
, vol.359
, pp. 741-746
-
-
Margreiter, R.1
-
41
-
-
0036139867
-
Glucose metabolism in the first 3 years after renal transplantation in patients receiving tacrolimus versus cyclosporine-based immuno-suppression
-
van Duijnhoven EM, Christiaans MH, Boots JM, et al. Glucose metabolism in the first 3 years after renal transplantation in patients receiving tacrolimus versus cyclosporine-based immuno-suppression. J Am Soc Nephrol 2002; 13: 213-20
-
(2002)
J Am Soc Nephrol
, vol.13
, pp. 213-220
-
-
Van Duijnhoven, E.M.1
Christiaans, M.H.2
Boots, J.M.3
-
42
-
-
0141595345
-
Ethnic disparities in type 2 diabetes: Pathophysiology and implications for prevention and management
-
Dagogo-Jack S. Ethnic disparities in type 2 diabetes: pathophysiology and implications for prevention and management. J Natl Med Assoc 2003; 95: 779-89
-
(2003)
J Natl Med Assoc
, vol.95
, pp. 779-789
-
-
Dagogo-Jack, S.1
-
43
-
-
0037183179
-
Outcomes of African American kidney transplant recipients treated with sirolimus, tacrolimus, and corticosteroids
-
Hricik DE, Anton HA, Knauss TC, et al. Outcomes of African American kidney transplant recipients treated with sirolimus, tacrolimus, and corticosteroids. Transplantation 2002; 74: 189-93
-
(2002)
Transplantation
, vol.74
, pp. 189-193
-
-
Hricik, D.E.1
Anton, H.A.2
Knauss, T.C.3
-
44
-
-
22244452014
-
Increased risk of post-transplant diabetes mellitus despite early steroid discontinuation in Hispanic kidney transplant recipients
-
Walczak DA, Calvert D, Jarzembowski TM, et al. Increased risk of post-transplant diabetes mellitus despite early steroid discontinuation in Hispanic kidney transplant recipients. Clin Transplant 2005; 19: 527-31
-
(2005)
Clin Transplant
, vol.19
, pp. 527-531
-
-
Walczak, D.A.1
Calvert, D.2
Jarzembowski, T.M.3
-
45
-
-
0036012951
-
Metabolic differences between Caucasian and African-American children and the relationship to type 2 diabetes mellitus
-
Arslanian SA. Metabolic differences between Caucasian and African-American children and the relationship to type 2 diabetes mellitus. J Pediatr Endocrinol 2002; 15 Suppl. 1: 509-17
-
(2002)
J Pediatr Endocrinol
, vol.15
, Issue.SUPPL. 1
, pp. 509-517
-
-
Arslanian, S.A.1
-
46
-
-
0036012944
-
Impaired beta-cell and alpha-cell function in African-American children with type 2 diabetes mellitus: Flatbush diabetes
-
Banerji MA. Impaired beta-cell and alpha-cell function in African-American children with type 2 diabetes mellitus: flatbush diabetes. J Pediatr Endocrinol 2002; 15 Suppl. 1: 493-501
-
(2002)
J Pediatr Endocrinol
, vol.15
, Issue.SUPPL. 1
, pp. 493-501
-
-
Banerji, M.A.1
-
47
-
-
7244226498
-
Development of diabetes mellitus following kidney transplantation: A Canadian experience
-
Gourishankar S, Jhangri GS, Tonelli M, et al. Development of diabetes mellitus following kidney transplantation: a Canadian experience. Am J Transplant 2004; 4: 1876-82
-
(2004)
Am J Transplant
, vol.4
, pp. 1876-1882
-
-
Gourishankar, S.1
Jhangri, G.S.2
Tonelli, M.3
-
49
-
-
29544442822
-
Posttransplantation diabetes mellitus: Prevalence and risk factors
-
Baltar J, Ortega T, Ortega F, et al. Posttransplantation diabetes mellitus: prevalence and risk factors. Transplant Proc 2005; 37: 3817-8
-
(2005)
Transplant Proc
, vol.37
, pp. 3817-3818
-
-
Baltar, J.1
Ortega, T.2
Ortega, F.3
-
50
-
-
29144458884
-
Clinical and genetic risk factors for posttransplant diabetes mellitus in adult renal transplant recipients treated with tacrolimus
-
Numakura K, Satoh S, Tsuchiya N, et al. Clinical and genetic risk factors for posttransplant diabetes mellitus in adult renal transplant recipients treated with tacrolimus. Transplantation 2005; 80: 1419-24
-
(2005)
Transplantation
, vol.80
, pp. 1419-1424
-
-
Numakura, K.1
Satoh, S.2
Tsuchiya, N.3
-
51
-
-
20344401339
-
Factors influencing the onset of diabetes mellitus after kidney transplantation: A single French center experience
-
Marin M, Renoult E, Bondor CI, et al. Factors influencing the onset of diabetes mellitus after kidney transplantation: a single French center experience. Transplant Proc 2005; 37: 1851-6
-
(2005)
Transplant Proc
, vol.37
, pp. 1851-1856
-
-
Marin, M.1
Renoult, E.2
Bondor, C.I.3
-
52
-
-
0042810786
-
Age and glucose intolerance: Effect of fitness and fatness
-
Reaven G. Age and glucose intolerance: effect of fitness and fatness. Diabetes Care 2003; 26: 539-40
-
(2003)
Diabetes Care
, vol.26
, pp. 539-540
-
-
Reaven, G.1
-
53
-
-
0030045106
-
Age-related alteration of pancreatic beta-cell function: Increased proinsulin and proinsulin-to-insulin molar ratio in elderly, but not in obese, subjects without glucose intolerance
-
Shimizu M, Kawazu S, Tomono S, et al. Age-related alteration of pancreatic beta-cell function: increased proinsulin and proinsulin-to-insulin molar ratio in elderly, but not in obese, subjects without glucose intolerance. Diabetes Care 1996; 19: 8-11
-
(1996)
Diabetes Care
, vol.19
, pp. 8-11
-
-
Shimizu, M.1
Kawazu, S.2
Tomono, S.3
-
54
-
-
0042810827
-
Aging per se does not influence glucose homeostasis: In vivo and in vitro evidence
-
Imbeault P, Prins JB, Stolic M, et al. Aging per se does not influence glucose homeostasis: in vivo and in vitro evidence. Diabetes Care 2003; 26: 480-4
-
(2003)
Diabetes Care
, vol.26
, pp. 480-484
-
-
Imbeault, P.1
Prins, J.B.2
Stolic, M.3
-
55
-
-
4344581405
-
Disruption of the SH2-B gene causes age-dependent insulin resistance and glucose intolerance
-
Duan C, Yang H, White MF, et al. Disruption of the SH2-B gene causes age-dependent insulin resistance and glucose intolerance. Mol Cell Biol 2004; 24: 7435-43
-
(2004)
Mol Cell Biol
, vol.24
, pp. 7435-7443
-
-
Duan, C.1
Yang, H.2
White, M.F.3
-
56
-
-
0037231817
-
Post-transplant hyperglycemia: A study of risk factors
-
Mathew JT, Rao M, Job V, et al. Post-transplant hyperglycemia: a study of risk factors. Nephrol Dial Transplant 2003; 18: 164-71
-
(2003)
Nephrol Dial Transplant
, vol.18
, pp. 164-171
-
-
Mathew, J.T.1
Rao, M.2
Job, V.3
-
57
-
-
5444245634
-
Hepatitis C virus-associated extrahepatic manifestations: A review
-
Sene D, Limal N, Cacoub P. Hepatitis C virus-associated extrahepatic manifestations: a review. Metab Brain Dis 2004; 19: 357-81
-
(2004)
Metab Brain Dis
, vol.19
, pp. 357-381
-
-
Sene, D.1
Limal, N.2
Cacoub, P.3
-
58
-
-
3142590775
-
Association of diabetes and hepatitis C infection: Epidemiologic evidence and pathophysiologic insights
-
Bahtiyar G, Shin JJ, Aytaman A, et al. Association of diabetes and hepatitis C infection: epidemiologic evidence and pathophysiologic insights. Curr Diab Rep 2004; 4: 194-8
-
(2004)
Curr Diab Rep
, vol.4
, pp. 194-198
-
-
Bahtiyar, G.1
Shin, J.J.2
Aytaman, A.3
-
59
-
-
27644508836
-
Review article: An unexpected virus-host interaction: The hepatitis C virus-diabetes link
-
Ratziu V, Heurtier A, Bonyhay L, et al. Review article: an unexpected virus-host interaction: the hepatitis C virus-diabetes link. Aliment Pharmacol Ther 2005; 22 Suppl. 2: 56-60
-
(2005)
Aliment Pharmacol Ther
, vol.22
, Issue.SUPPL. 2
, pp. 56-60
-
-
Ratziu, V.1
Heurtier, A.2
Bonyhay, L.3
-
60
-
-
0030047625
-
Erythrocyte membrane fluidity in adult polycystic kidney disease: Difference between intact cells and ghost membranes
-
Vareesangthip K, Thomas TH, Tong P, et al. Erythrocyte membrane fluidity in adult polycystic kidney disease: difference between intact cells and ghost membranes. Eur J Clin Invest 1996; 26: 171-3
-
(1996)
Eur J Clin Invest
, vol.26
, pp. 171-173
-
-
Vareesangthip, K.1
Thomas, T.H.2
Tong, P.3
-
61
-
-
85047699165
-
Abnormal effect of thiol groups on erythrocyte Na/Li counter transport kinetics in adult polycystic kidney disease
-
Vareesangthip K, Thomas TH, Wilkinson R. Abnormal effect of thiol groups on erythrocyte Na/Li counter transport kinetics in adult polycystic kidney disease. Nephrol Dial Transplant 1995; 10: 2219-23
-
(1995)
Nephrol Dial Transplant
, vol.10
, pp. 2219-2223
-
-
Vareesangthip, K.1
Thomas, T.H.2
Wilkinson, R.3
-
62
-
-
0030875694
-
Insulin resistance in adult polycystic kidney disease
-
Vareesangthip K, Tong P, Wilkinson R, et al. Insulin resistance in adult polycystic kidney disease. Kidney Int 1997; 52: 503-8
-
(1997)
Kidney Int
, vol.52
, pp. 503-508
-
-
Vareesangthip, K.1
Tong, P.2
Wilkinson, R.3
-
63
-
-
12344333418
-
Autosomal-dominant polycystic kidney disease as a risk factor for diabetes mellitus following renal transplantation
-
de Mattos AM, Olyaei AJ, Prather JC, et al. Autosomal-dominant polycystic kidney disease as a risk factor for diabetes mellitus following renal transplantation. Kidney Int 2005; 67: 714-20
-
(2005)
Kidney Int
, vol.67
, pp. 714-720
-
-
De Mattos, A.M.1
Olyaei, A.J.2
Prather, J.C.3
-
64
-
-
33645422488
-
Family history of type 2 diabetes: A population-based screening tool for prevention?
-
Hariri S, Yoon PW, Qureshi N, et al. Family history of type 2 diabetes: a population-based screening tool for prevention? Genet Med 2006; 8: 102-8
-
(2006)
Genet Med
, vol.8
, pp. 102-108
-
-
Hariri, S.1
Yoon, P.W.2
Qureshi, N.3
-
65
-
-
26444613340
-
Is HLA-DR6 a protective factor against posttransplantation diabetes mellitus?
-
Nafar M, Pour-Reza-Gholi F, Amouzegar A, et al. Is HLA-DR6 a protective factor against posttransplantation diabetes mellitus? Transplant Proc 2005; 37: 3098-100
-
(2005)
Transplant Proc
, vol.37
, pp. 3098-3100
-
-
Nafar, M.1
Pour-Reza-Gholi, F.2
Amouzegar, A.3
-
66
-
-
0033661749
-
Identification of glucokinase mutation in subjects with post-renal transplantation diabetes mellitus
-
Nam JH, Lee HC, Kim YH, et al. Identification of glucokinase mutation in subjects with post-renal transplantation diabetes mellitus. Diabet Res Clin Pract 2000; 50: 169-76
-
(2000)
Diabet Res Clin Pract
, vol.50
, pp. 169-176
-
-
Nam, J.H.1
Lee, H.C.2
Kim, Y.H.3
-
67
-
-
0347761625
-
Obesity as an independent predictor of posttransplant diabetes mellitus
-
Parikh CR, Klem P, Wong C, et al. Obesity as an independent predictor of posttransplant diabetes mellitus. Transplant Proc 2003; 35: 2922-6
-
(2003)
Transplant Proc
, vol.35
, pp. 2922-2926
-
-
Parikh, C.R.1
Klem, P.2
Wong, C.3
-
68
-
-
0033571518
-
Quantitative assessment of the first acute rejection as a predictor of renal transplant outcome
-
Ishikawa A, Flechner SM, Goldfarb DA, et al. Quantitative assessment of the first acute rejection as a predictor of renal transplant outcome. Transplantation 1999; 68: 1318-24
-
(1999)
Transplantation
, vol.68
, pp. 1318-1324
-
-
Ishikawa, A.1
Flechner, S.M.2
Goldfarb, D.A.3
-
70
-
-
4043137272
-
Prevalence and immunohistochemical findings of subclinical kidney allograft rejection and its association with graft outcome
-
Veronese FV, Noronha IL, Manfro RC, et al. Prevalence and immunohistochemical findings of subclinical kidney allograft rejection and its association with graft outcome. Clin Transplant 2004; 18: 357-64
-
(2004)
Clin Transplant
, vol.18
, pp. 357-364
-
-
Veronese, F.V.1
Noronha, I.L.2
Manfro, R.C.3
-
71
-
-
33644860184
-
Estimated one-year glomerular filtration rate is the best predictor of long-term graft function following renal transplant
-
Salvadori M, Rosati A, Bock A, et al. Estimated one-year glomerular filtration rate is the best predictor of long-term graft function following renal transplant. Transplantation 2006; 81: 202-6
-
(2006)
Transplantation
, vol.81
, pp. 202-206
-
-
Salvadori, M.1
Rosati, A.2
Bock, A.3
-
72
-
-
0030754436
-
Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age
-
Hjelmesaeth J, Hartmann A, Kofstad J, et al. Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age. Transplantation 1997; 64: 979-83
-
(1997)
Transplantation
, vol.64
, pp. 979-983
-
-
Hjelmesaeth, J.1
Hartmann, A.2
Kofstad, J.3
-
73
-
-
0036675855
-
Diabetes mellitus and hypertension: Key risk factors for kidney disease
-
Lea JP, Nicholas SB. Diabetes mellitus and hypertension: key risk factors for kidney disease. J Natl Med Assoc 2002; 94 Suppl. 8: 7S-15S
-
(2002)
J Natl Med Assoc
, vol.94
, Issue.SUPPL. 8
-
-
Lea, J.P.1
Nicholas, S.B.2
-
74
-
-
0034594631
-
Arterial hypertension and renal allograft survival
-
Mange KC, Cizman B, Joffe M, et al. Arterial hypertension and renal allograft survival. JAMA 2000; 283: 633-8
-
(2000)
JAMA
, vol.283
, pp. 633-638
-
-
Mange, K.C.1
Cizman, B.2
Joffe, M.3
-
75
-
-
2542464211
-
Hypertension after kidney transplantation
-
Kasiske BL, Anjum S, Shah R, et al. Hypertension after kidney transplantation. Am J Kidney Dis 2004; 43: 1071-81
-
(2004)
Am J Kidney Dis
, vol.43
, pp. 1071-1081
-
-
Kasiske, B.L.1
Anjum, S.2
Shah, R.3
-
76
-
-
15844420109
-
Hypertension, antihypertensive agents and outcomes following renal transplantation
-
Tutone VK, Mark PB, Stewart GA, et al. Hypertension, antihypertensive agents and outcomes following renal transplantation. Clin Transplant 2005; 19: 181-92
-
(2005)
Clin Transplant
, vol.19
, pp. 181-192
-
-
Tutone, V.K.1
Mark, P.B.2
Stewart, G.A.3
-
77
-
-
26444553365
-
High incidence of early posttransplantation diabetes mellitus in an eastern population
-
Mohsin N, Budruddin M, Pakkyara A, et al. High incidence of early posttransplantation diabetes mellitus in an eastern population. Transplant Proc 2005; 37: 3093-4
-
(2005)
Transplant Proc
, vol.37
, pp. 3093-3094
-
-
Mohsin, N.1
Budruddin, M.2
Pakkyara, A.3
-
78
-
-
0031754125
-
Glipizide treatment of post-transplant diabetes does not interfere with cyclosporine pharmacokinetics in renal allograft recipients
-
Sagedal S, Asberg A, Hartmann A, et al. Glipizide treatment of post-transplant diabetes does not interfere with cyclosporine pharmacokinetics in renal allograft recipients. Clin Transplant 1998; 12: 553-6
-
(1998)
Clin Transplant
, vol.12
, pp. 553-556
-
-
Sagedal, S.1
Asberg, A.2
Hartmann, A.3
-
79
-
-
29144443855
-
Rosiglitazone therapy of posttransplant diabetes mellitus
-
Villanueva G, Baldwin D. Rosiglitazone therapy of posttransplant diabetes mellitus. Transplantation 2005; 80: 1402-5
-
(2005)
Transplantation
, vol.80
, pp. 1402-1405
-
-
Villanueva, G.1
Baldwin, D.2
-
81
-
-
33750529422
-
Effect of steroid withdrawal on new onset diabetes after transplant: Results of a randomized double blinded placebo controlled trial
-
[abstract 856] Jul 22-27; Boston
-
Pirsch J, Woodle ES, Shihab F, et al. Effect of steroid withdrawal on new onset diabetes after transplant: results of a randomized double blinded placebo controlled trial [abstract 856]. World Transplant Congress; 2006 Jul 22-27; Boston
-
(2006)
World Transplant Congress
-
-
Pirsch, J.1
Woodle, E.S.2
Shihab, F.3
-
82
-
-
7244245756
-
Predictors of success in conversion from calcineurin inhibitor to sirolimus for chronic allograft dysfunction
-
Diekmann F, Budde K, Oppenheimer F, et al. Predictors of success in conversion from calcineurin inhibitor to sirolimus for chronic allograft dysfunction. Am J Transplant 2004; 4: 1869-75
-
(2004)
Am J Transplant
, vol.4
, pp. 1869-1875
-
-
Diekmann, F.1
Budde, K.2
Oppenheimer, F.3
-
83
-
-
33644694497
-
A randomized controlled trial of late conversion from CNI-based to sirolimus-based immunosuppression following renal transplantation
-
Watson CJ, Firth J, Williams PF, et al. A randomized controlled trial of late conversion from CNI-based to sirolimus-based immunosuppression following renal transplantation. Am J Transplant 2005; 5: 2496-503
-
(2005)
Am J Transplant
, vol.5
, pp. 2496-2503
-
-
Watson, C.J.1
Firth, J.2
Williams, P.F.3
-
84
-
-
21644457432
-
Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation
-
Oberbauer R, Segoloni G, Campistol JM, et al. Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation. Transpl Int 2005; 18: 22-8
-
(2005)
Transpl Int
, vol.18
, pp. 22-28
-
-
Oberbauer, R.1
Segoloni, G.2
Campistol, J.M.3
-
85
-
-
7244247370
-
Reduced incidence of new onset diabetes mellitus after renal transplantation with 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins)
-
Prasad GV, Kim SJ, Huang M, et al. Reduced incidence of new onset diabetes mellitus after renal transplantation with 3-hydroxy-3-methylglutaryl- coenzyme A reductase inhibitors (statins). Am J Transplant 2004; 4: 1897-903
-
(2004)
Am J Transplant
, vol.4
, pp. 1897-1903
-
-
Prasad, G.V.1
Kim, S.J.2
Huang, M.3
-
86
-
-
0037184316
-
Kidney transplantation without calcineurin inhibitor drugs: A prospective, randomized trial of sirolimus versus cyclosporine
-
Flechner SM, Goldfarb D, Modlin C, et al. Kidney transplantation without calcineurin inhibitor drugs: a prospective, randomized trial of sirolimus versus cyclosporine. Transplantation 2002; 74: 1070-6
-
(2002)
Transplantation
, vol.74
, pp. 1070-1076
-
-
Flechner, S.M.1
Goldfarb, D.2
Modlin, C.3
-
87
-
-
21044443129
-
A calcineurin antagonist-free induction/maintenance strategy for immunosuppression in elderly recipients of renal allografts from elderly cadaver donors: Long-term results from a prospective single centre trial
-
Arbogast H, Huckelheim H, Schneeberger H, et al. A calcineurin antagonist-free induction/maintenance strategy for immunosuppression in elderly recipients of renal allografts from elderly cadaver donors: long-term results from a prospective single centre trial. Clin Transplant 2005; 19: 309-15
-
(2005)
Clin Transplant
, vol.19
, pp. 309-315
-
-
Arbogast, H.1
Huckelheim, H.2
Schneeberger, H.3
-
88
-
-
2342596401
-
Comparison of sirolimus based calcineurin inhibitor sparing and calcineurin inhibitor-free regimens in cadaveric renal transplantation
-
Lo A, Egidi MF, Gaber LW, et al. Comparison of sirolimus based calcineurin inhibitor sparing and calcineurin inhibitor-free regimens in cadaveric renal transplantation. Transplantation 2004; 77: 1228-35
-
(2004)
Transplantation
, vol.77
, pp. 1228-1235
-
-
Lo, A.1
Egidi, M.F.2
Gaber, L.W.3
-
89
-
-
33644678828
-
Comparison of sirolimus with low-dose tacrolimus vs sirolimus-based calcineurin inhibitor-free regimen in live donor renal transplantation
-
Hamdy AF, El-Agroudy A, Bakr MA, et al. Comparison of sirolimus with low-dose tacrolimus vs sirolimus-based calcineurin inhibitor-free regimen in live donor renal transplantation. Am J Transplant 2005; 5: 2531-8
-
(2005)
Am J Transplant
, vol.5
, pp. 2531-2538
-
-
Hamdy, A.F.1
El-Agroudy, A.2
Bakr, M.A.3
-
90
-
-
0037472871
-
Reducing cardiovascular risk in type 2 diabetes
-
Solomon CG. Reducing cardiovascular risk in type 2 diabetes. N Engl J Med 2003; 348: 457-9
-
(2003)
N Engl J Med
, vol.348
, pp. 457-459
-
-
Solomon, C.G.1
-
91
-
-
0037034257
-
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
-
Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403
-
(2002)
N Engl J Med
, vol.346
, pp. 393-403
-
-
Knowler, W.C.1
Barrett-Connor, E.2
Fowler, S.E.3
-
92
-
-
0032809728
-
Patient survival after renal transplantation: II. The impact of smoking
-
Cosio FG, Falkenhain ME, Pesavento TE, et al. Patient survival after renal transplantation: II. The impact of smoking. Clin Transplant 1999; 13: 336-41
-
(1999)
Clin Transplant
, vol.13
, pp. 336-341
-
-
Cosio, F.G.1
Falkenhain, M.E.2
Pesavento, T.E.3
-
93
-
-
0037472879
-
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes
-
Gaede P, Vedel P, Larsen N, et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003; 348: 383-93
-
(2003)
N Engl J Med
, vol.348
, pp. 383-393
-
-
Gaede, P.1
Vedel, P.2
Larsen, N.3
-
94
-
-
33645462551
-
Prevention and treatment of diabetic renal disease in type 2 diabetes: The BENEDICT study
-
Remuzzi G, Perico N, Macia M, et al. Prevention and treatment of diabetic renal disease in type 2 diabetes: the BENEDICT study. J Am Soc Nephrol 2006; 17 Suppl. 2: S90-7
-
(2006)
J Am Soc Nephrol
, vol.17
, Issue.SUPPL. 2
-
-
Remuzzi, G.1
Perico, N.2
Macia, M.3
-
95
-
-
0037432304
-
Prevention of heart failure in patients in the Heart Outcomes Prevention Evaluation (HOPE) Study
-
Arnold JM, Yusuf S, Young J, et al. Prevention of heart failure in patients in the Heart Outcomes Prevention Evaluation (HOPE) Study. Circulation 2003; 107: 1284-90
-
(2003)
Circulation
, vol.107
, pp. 1284-1290
-
-
Arnold, J.M.1
Yusuf, S.2
Young, J.3
-
96
-
-
30944435875
-
Angiotensin II antagonists: Therapeutic benefits spanning the cardiovascular disease continuum from hypertension to heart failure and diabetic nephropathy
-
Ribeirio AB. Angiotensin II antagonists: therapeutic benefits spanning the cardiovascular disease continuum from hypertension to heart failure and diabetic nephropathy. Curr Med Res Opin 2006; 22: 1-16
-
(2006)
Curr Med Res Opin
, vol.22
, pp. 1-16
-
-
Ribeirio, A.B.1
-
97
-
-
2942566086
-
Outcome at 3 years with a prednisone-free maintenance regimen: A single-center experience with 349 kidney transplant recipients
-
Khwaja K, Asolati M, Harmon JV, et al. Outcome at 3 years with a prednisone-free maintenance regimen: a single-center experience with 349 kidney transplant recipients. Am J Transplant 2004; 4: 980-7
-
(2004)
Am J Transplant
, vol.4
, pp. 980-987
-
-
Khwaja, K.1
Asolati, M.2
Harmon, J.V.3
-
98
-
-
31044449097
-
Five years of steroid sparing in renal transplantation with tacrolimus and mycophenolate mofetil
-
Borrows R, Chan K, Loucaidou M, et al. Five years of steroid sparing in renal transplantation with tacrolimus and mycophenolate mofetil. Transplantation 2006; 81: 125-8
-
(2006)
Transplantation
, vol.81
, pp. 125-128
-
-
Borrows, R.1
Chan, K.2
Loucaidou, M.3
-
99
-
-
27644470998
-
Prevention of osteoporotic fractures in the elderly
-
Wilkins CH, Birge SJ. Prevention of osteoporotic fractures in the elderly. Am J Med 2005; 118: 1190-5
-
(2005)
Am J Med
, vol.118
, pp. 1190-1195
-
-
Wilkins, C.H.1
Birge, S.J.2
-
100
-
-
0346754948
-
Bone mineral density changes within six months of renal transplantation
-
Mikuls TR, Julian BA, Bartolucci A, et al. Bone mineral density changes within six months of renal transplantation. Transplantation 2003; 75: 49-54
-
(2003)
Transplantation
, vol.75
, pp. 49-54
-
-
Mikuls, T.R.1
Julian, B.A.2
Bartolucci, A.3
-
102
-
-
33748075128
-
Effects of bisphosphonates on bone loss in the first year after renal transplantation: A meta-analysis of randomized controlled trials
-
Mitterbauer C, Schwarz C, Haas M, et al. Effects of bisphosphonates on bone loss in the first year after renal transplantation: a meta-analysis of randomized controlled trials. Nephrol Dial Transplant 2006; 21: 2275-81
-
(2006)
Nephrol Dial Transplant
, vol.21
, pp. 2275-2281
-
-
Mitterbauer, C.1
Schwarz, C.2
Haas, M.3
-
103
-
-
1342304173
-
Lymphomas after solid organ transplantation: A collaborative transplant study report
-
Opelz G, Dohler B. Lymphomas after solid organ transplantation: a collaborative transplant study report. Am J Transplant 2004; 4: 222-30
-
(2004)
Am J Transplant
, vol.4
, pp. 222-230
-
-
Opelz, G.1
Dohler, B.2
-
104
-
-
28544449370
-
Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression
-
Caillard S, Dharnidharka V, Agodoa L, et al. Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression. Transplantation 2005; 80: 1233-43
-
(2005)
Transplantation
, vol.80
, pp. 1233-1243
-
-
Caillard, S.1
Dharnidharka, V.2
Agodoa, L.3
-
105
-
-
27644436740
-
Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies
-
Kauffman HM, Cherikh WS, Cheng Y, et al. Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies. Transplantation 2005; 80: 883-9
-
(2005)
Transplantation
, vol.80
, pp. 883-889
-
-
Kauffman, H.M.1
Cherikh, W.S.2
Cheng, Y.3
-
106
-
-
33645458234
-
Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation
-
Campistol JM, Eris J, Oberbauer R. Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation. J Am Soc Nephrol 2006; 17: 581-9
-
(2006)
J Am Soc Nephrol
, vol.17
, pp. 581-589
-
-
Campistol, J.M.1
Eris, J.2
Oberbauer, R.3
|